文献速递区域麻醉与超声术前评估与围术期医学

乳腺癌手术中胸肌间-胸锯肌平面阻滞后局麻药血清浓度:药代动力学研究

Serum concentrations of local anesthetics after unilateral interpectoral-pectoserratus plane block in breast cancer surgery: a pharmacokinetic study.
PubMed 文献 · Reg Anesth Pain Med · 2023-02-14

该研究纳入22例择期单侧乳腺癌手术患者,在全麻联合超声引导下胸肌间-胸锯肌平面阻滞(罗哌卡因2.5 mg/kg)后多时间点采血。20例样本分析显示,50%患者游离罗哌卡因浓度超过潜在毒性阈值0.15 µg/mL,平均峰浓度出现在注射后20分钟。

要点

  • 2.5 mg/kg罗哌卡因胸肌间-胸锯肌平面阻滞有局麻药全身毒性风险
  • 50%患者游离罗哌卡因浓度超过0.15 µg/mL毒性阈值
  • 平均峰浓度出现在注射后20分钟,需加强早期监测

核心结论

  • 2.5 mg/kg罗哌卡因胸肌间-胸锯肌平面阻滞可能导致游离罗哌卡因浓度超过局麻药全身毒性阈值。

研究设计与样本

  • 药代动力学研究,纳入22例择期单侧乳腺癌手术患者,全麻联合超声引导胸肌间-胸锯肌平面阻滞,注射罗哌卡因2.5 mg/kg。
  • 于0(两次)、10、20、30、45、60、90、120分钟及4小时共采集10次静脉血,测定游离及总罗哌卡因浓度,并监测白蛋白和α1-酸性糖蛋白。

主要发现

  • 20例患者样本纳入分析,罗哌卡因平均剂量为172.8(22.5)mg。
  • 50%患者游离罗哌卡因浓度超过潜在毒性阈值0.15 µg/mL。
  • 平均血清峰浓度出现在注射后20分钟。

关键数值与推荐

  • 游离罗哌卡因潜在毒性阈值为0.15 µg/mL,50%患者超过该阈值。

临床怎么用

  • 行胸肌间-胸锯肌平面阻滞使用2.5 mg/kg罗哌卡因时,应警惕局麻药全身毒性,尤其在注射后20分钟峰值附近加强监测。

局限性

  • 样本量较小(22例纳入,20例分析),仅研究单侧乳腺癌手术人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The ultrasound-guided interpectoral-pectoserratus plane block is a fascial plane block for superficial surgery of the anterolateral chest wall. This technique involves injecting a relatively large volume of local anesthetics (typically 30 mL of 0.25%-0.50%, ie, 75-150 mg ropivacaine) underneath the major and minor pectoral muscles of the anterior thoracic wall. There is a potential risk of toxic serum concentrations of local anesthetics due to systemic absorption. METHODS: 22 patients scheduled for elective unilateral breast cancer surgery were included in this study. All surgery was performed with general anesthesia and an ultrasound-guided interpectoral-pectoserratus plane block with 2.5 mg/kg ropivacaine. Ten venous blood samples were collected at 0 (two samples) 10, 20, 30, 45, 60, 90 and 120 min and at 4 hours after performing the block. Free and total ropivacaine levels were measured at each time point. Albumin and alpha-1-acid-glycoprotein were measured to monitor shifts between the free and bound fraction of ropivacaine. RESULTS: Samples of 20 patients were analyzed. The mean dose of ropivacaine was 172.8 (22.5) mg. In 50% of the patients, the potentially toxic threshold of 0.15 µg/mL free ropivacaine concentration was exceeded. Mean peak serum concentration occurred at 20 min postinjection. CONCLUSIONS: This pharmacokinetic study demonstrated that a 2.5 mg/kg ropivacaine interpectoral-pectoserratus plane block may result in exceeding the threshold for local anesthetic systemic toxicity.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Versyck B, Vermeylen K, Willemse J, et al. Serum concentrations of local anesthetics after unilateral interpectoral-pectoserratus plane block in breast cancer surgery: a pharmacokinetic study. Reg Anesth Pain Med. 2023. PMID: 36787951. doi:10.1136/rapm-2022-104166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。